Table 2 Prevalence of most common instances of potentially inappropriate prescribing among 287 people with dementia
STOPP criterion description (potential risk) | Number of patients | % of patients |
|---|---|---|
Any drug prescribed beyond the recommended duration, where treatment duration is well defined. | 90 | 31.4 |
Any drug prescribed without an evidence-based clinical indication. | 78 | 27.2 |
PPI for uncomplicated PUD or erosive peptic oesophagitis at full therapeutic dosage for > 8 weeks (dose reduction or earlier discontinuation indicated) | 75 | 26.0 |
AchEIs with a known history of persistent bradycardia (< 60 beats/min), heart block or recurrent unexplained syncope or concurrent treatment with drugs that reduce heart rate such as beta blockers, digoxin, diltiazem, verapamil (risk of cardiac conduction failure, syncope, and injury) | 60 | 21.0 |
Anticholinergics/ antimuscarinics in patients with delirium or dementia (risk of exacerbation of cognitive impairment) | 28 | 9.8 |